Leiter’s Compounding Begins Operations From Outsourcing Facility

Share Article

Company finalizes move into cGMP facility and begins production and nationwide shipments

Registering as an Outsourcing Facility allows for additional industry oversight.

Leiter’s Compounding, a full service compounding center and Outsourcing Facility, announced today that they have begun production from their new state-of-the-art US Headquarters and laboratory.

The 22,000-square-foot facility, one of the largest of its kind in the country, serves patients and facilities in 49 states and other international locations.

“Outsourcing Facility registration, including additional FDA oversight, is a concept we have always agreed with,” said Charles Leiter, CEO & President. “We will still abide by state boards of pharmacy regulations, but registering as an Outsourcing Facility allows for additional industry oversight. Facilities, prescribing Physicians, and patients can count on products produced from our Outsourcing Facility to be the highest quality in the industry.”

About Leiter’s Compounding

Leiter’s Compounding is a compounding facility located in San Jose, California. Leiter’s has sterile and non-sterile clean rooms and compounds over 11,000 custom prescription medications. It is the industry leader in ophthalmic compounds and solutions. It is currently operated by President and CEO Charles Leiter, Pharm. D. Leiter’s Compounding Pharmacy has compounded more than 1 million sterile doses in the last 25 years. Visit Leiter’s Compounding online at http://www.leiterrx.com

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Steven Shepherd
Leiter's Compounding
+1 (800) 292-6772 Ext: 2945
Email >
Follow >
Visit website